Detalhe da pesquisa
1.
[Translated article] Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists.
Actas Dermosifiliogr
; 115(5): T449-T457, 2024 May.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-38479699
2.
Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP). / Supervivencia de la ciclosporina en el tratamiento de la dermatitis atópica moderada-grave: Registro Español de Dermatitis Atópica (BIOBADATOP).
Actas Dermosifiliogr
; 115(4): 341-346, 2024 Apr.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-37482292
3.
[Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).
Actas Dermosifiliogr
; 115(4): T341-T346, 2024 Apr.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-38325545
4.
Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists. / Aproximación a la epidemiología, manejo de la enfermedad y retos actuales en la gestión de la psoriasis pustulosa generalizada en España a través de un cuestionario dirigido a dermatólogos.
Actas Dermosifiliogr
; 2023 Nov 02.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-37925068
5.
Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
Br J Dermatol
; 186(1): 142-152, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34254291
6.
Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience. / Psoriasis moderada-grave en pacientes pediátricos y jóvenes: experiencia en el registro BIOBADADERM.
Actas Dermosifiliogr
; 113(4): 401-406, 2022 Apr.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-35428502
7.
Definition of minimal disease activity in psoriasis.
J Eur Acad Dermatol Venereol
; 35(2): 422-430, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32367536
8.
Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group.
J Eur Acad Dermatol Venereol
; 34(12): 2821-2829, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32271966
9.
IL17RA gene variants and anti-TNF response among psoriasis patients.
Pharmacogenomics J
; 18(1): 76-80, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27670766
10.
Erythrodermic Psoriasis Has Become Less Frequent: Results From the Biobadaderm Registry.
Actas Dermosifiliogr
; 114(4): 366-369, 2023 04.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-36563780
11.
Erythrodermic Psoriasis Has Become Less Frequent: Results From the Biobadaderm Registry. / [Artículo traducido] La psoriasis eritrodérmica es cada vez menos frecuente: resultados del registro Biobadaderm.
Actas Dermosifiliogr
; 114(4): T366-T369, 2023 04.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-36738778
12.
Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) breastfeed less when compared with general population.
J Eur Acad Dermatol Venereol
; 36(3): e205-e207, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34626521
13.
Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.
J Eur Acad Dermatol Venereol
; 31(6): 1021-1028, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28252811
14.
Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm.
J Eur Acad Dermatol Venereol
; 31(10): 1700-1708, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28485816
15.
Reliability of the MDi Psoriasis® Application to Aid Therapeutic Decision-Making in Psoriasis. / Fiabilidad de una aplicación de ayuda a la toma de decisiones terapéuticas en el paciente con psoriasis (MDi Psoriasis®).
Actas Dermosifiliogr
; 108(7): 650-656, 2017 Sep.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-28385425
16.
Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry. / Manejo de los tratamientos biológicos en pacientes con psoriasis moderada-grave sometidos a intervenciones quirúrgicas en el registro español Biobadaderm.
Actas Dermosifiliogr
; 108(1): 52-58, 2017.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-27658689
17.
Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis.
J Eur Acad Dermatol Venereol
; 30(11): 1942-1950, 2016 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-27329511
18.
Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert Recommendations.
Actas Dermosifiliogr
; 107(3): 194-206, 2016 Apr.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-26614486
19.
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry.
J Eur Acad Dermatol Venereol
; 29(5): 858-64, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25185962
20.
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry.
J Eur Acad Dermatol Venereol
; 29(1): 156-63, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24684267